VCURA

Live / Applied — First extension granted (statement of use) (as of 15 Jan 2026)

What this means for you

Not registered yet, but its 15 Jul 2020 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90054114
Mark type
Stylized text
Filed
15 Jul 2020
Published for opposition
25 Feb 2025
Attorney of record
Nyall Engfield

Goods and services

  • Class 005 — Pharmaceuticals: pharmaceutical preparations with antiviral properties for use in the treatment of upper and lower respiratory infections, namely, flus and common colds caused by viruses, adenovirus, arbovirus, arenavirus, picornavirus, coronavirus, COVID-19, syncytial virus, hyperplastic skin lesions, topical herpes simplex virus 1 and 2; pharmaceutical preparations with antiviral properties for use in the treatment of influenza, parainfluenza and viral infections, namely, cold sores, genital herpes, varicella herpes, zoster 'shingles' and viral infections of the skin, namely, warts, skin tags and plantar warts, conjunctivitis, and herpetic keratitis

Owner

Prosecution history

  • 16 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 15 Jan 2026 — SOU EXTENSION 1 GRANTED
  • 21 Oct 2025 — SOU EXTENSION 1 FILED
  • 15 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 24 Nov 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
  • 24 Nov 2025 — NOTICE OF REVIVAL - E-MAILED
  • 24 Nov 2025 — PETITION TO REVIVE-GRANTED
  • 24 Nov 2025 — TEAS PETITION TO REVIVE RECEIVED
  • 24 Nov 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 24 Nov 2025 — ABANDONMENT - NO USE STATEMENT FILED
  • 22 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 25 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 25 Feb 2025 — PUBLISHED FOR OPPOSITION
  • 19 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 04 Feb 2025 — LAW OFFICE PUBLICATION REVIEW COMPLETED

View this trademark record on Marksy